NDRA News and Press, ENDRA Life Sciences Inc. From 09/06/22

ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of imaging technologies and Thermo Acoustic Enhanced UltraSound (TAEUS ® ), announces that management will present a company overview at the H.C. Wainwright 24 th Annual Global Investment Conference being held September...

ENDRA Life Sciences ( NASDAQ: NDRA ) said on Wednesday the European Patent Office had issued Patent for its TAEUS system to calculate fat concentration in the human body with multiple thermoacoustic measurements. The company has the same patent protection in the U.S. a...

ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of imaging technologies and Thermo Acoustic Enhanced UltraSound (TAEUS ® ), announces that the European Patent Office has issued European Patent No. 3730041 (the ‘041 patent) to ENDRA titled “System fo...

ENDRA Life Sciences Inc. (NDRA) Q2 2022 Earnings Conference Call August 15, 2022, 04:30 PM ET Company Participants Yvonne Briggs - IR Francois Michelon - Chairman and CEO Mike Thornton - Chief Technology Officer Renaud Maloberti - CCO Irina Pestrikova - S...

Endra Life Sciences press release ( NASDAQ: NDRA ): Q2 GAAP EPS of $0.06 beats by $0.12 . Cash and cash equivalents were $11.3 million as of June 30, 2022. For further details see: Endra Life Sciences GAAP EPS of $0.06 beats by $0.12

Conference call begins at 4:30 p.m. Eastern time today ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), today reported financial results for the three and six months ended June 30, 2022, and provided a busines...

Endra Life Sciences ( NASDAQ: NDRA ) is scheduled to announce Q2 earnings results on Monday, August 15th, after market close. The consensus EPS Estimate is -$0.06 Over the last 3 months, EPS estimates have seen 1 upward revision and 0 downward. Revenue estimates ha...

ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, today announced that the company will report financial results for the second quarter of 2022 on Monday, August 15, 2022 after the close of trading on the U.S. financial markets. Manageme...

TAEUS ® now protected by 53 patents issued globally, including 31 in the U.S. N ew U.S. patents expand potential licensing opportunities in data management ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of imaging technologies and Thermo Acou...

ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, today announced that management will be participating in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference being held August 15-16, 2022. Management will host one-on-one vi...